Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder
Archive ouverte
Amare, Azmeraw, T | Thalamuthu, Anbupalam | Schubert, Klaus, Oliver | Fullerton, Janice, M | Ahmed, Muktar | Hartmann, Simon | Papiol, Sergi | Heilbronner, Urs | Degenhardt, Franziska | Tekola-Ayele, Fasil | Hou, Liping | Hsu, Yi-Hsiang | Shekhtman, Tatyana | Adli, Mazda | Akula, Nirmala | Akiyama, Kazufumi | Ardau, Raffaella | Arias, Bárbara | Aubry, Jean-Michel | Hasler, Roland | Richard-Lepouriel, Hélène | Perroud, Nader | Backlund, Lena | Bhattacharjee, Abesh, Kumar | Bellivier, Frank | Benabarre, Antonio | Bengesser, Susanne | Biernacka, Joanna, M | Birner, Armin | Marie-Claire, Cynthia | Cervantes, Pablo | Chen, Hsi-Chung | Chillotti, Caterina | Cichon, Sven | Cruceanu, Cristiana | Czerski, Piotr, M | Dalkner, Nina | del Zompo, Maria | Depaulo, J, Raymond | Étain, Bruno | Jamain, Stephane | Falkai, Peter | Forstner, Andreas, J | Frisen, Louise | Frye, Mark, A | Gard, Sébastien | Garnham, Julie, S | Goes, Fernando, S | Grigoroiu-Serbanescu, Maria | Fallgatter, Andreas, J | Stegmaier, Sophia | Ethofer, Thomas | Biere, Silvia | Petrova, Kristiyana | Schuster, Ceylan | Adorjan, Kristina | Budde, Monika | Heilbronner, Maria | Kalman, Janos, L | Kohshour, Mojtaba, Oraki | Reich-Erkelenz, Daniela | Schaupp, Sabrina, K | Schulte, Eva, C | Senner, Fanny | Vogl, Thomas | Anghelescu, Ion-George | Arolt, Volker | Dannlowski, Udo | Dietrich, Detlef | Figge, Christian | Jäger, Markus | Lang, Fabian, U | Juckel, Georg | Konrad, Carsten | Reimer, Jens | Schmauß, Max | Schmitt, Andrea | Spitzer, Carsten | von Hagen, Martin | Wiltfang, Jens | Zimmermann, Jörg | Andlauer, Till, F M | Fischer, Andre | Bermpohl, Felix | Ritter, Philipp | Matura, Silke | Gryaznova, Anna | Falkenberg, Irina | Yildiz, Cüneyt | Kircher, Tilo | Schmidt, Julia | Koch, Marius | Gade, Kathrin | Trost, Sarah | Haussleiter, Ida, S | Lambert, Martin | Rohenkohl, Anja, C | Kraft, Vivien | Grof, Paul | Hashimoto, Ryota | Hauser, Joanna | Herms, Stefan | Hoffmann, Per | Jiménez, Esther | Kahn, Jean-Pierre | Kassem, Layla | Kuo, Po-Hsiu | Kato, Tadafumi | Kelsoe, John | Kittel-Schneider, Sarah | Ferensztajn-Rochowiak, Ewa | König, Barbara | Kusumi, Ichiro | Laje, Gonzalo | Landén, Mikael | Lavebratt, Catharina | Leboyer, Marion | Leckband, Susan, G | Tortorella, Alfonso | Manchia, Mirko | Martinsson, Lina | Mccarthy, Michael, J | Mcelroy, Susan | Colom, Francesc | Millischer, Vincent | Mitjans, Marina | Mondimore, Francis, M | Monteleone, Palmiero | Nievergelt, Caroline, M | Nöthen, Markus, M | Novák, Tomas | O’donovan, Claire | Ozaki, Norio | Pfennig, Andrea | Pisanu, Claudia | Potash, James, B | Reif, Andreas | Reininghaus, Eva | Rouleau, Guy, A | Rybakowski, Janusz, K | Schalling, Martin | Schofield, Peter, R | Schweizer, Barbara, W | Severino, Giovanni | Shilling, Paul, D | Shimoda, Katzutaka | Simhandl, Christian | Slaney, Claire, M | Squassina, Alessio | Stamm, Thomas | Stopkova, Pavla | Maj, Mario | Turecki, Gustavo | Vieta, Eduard | Veeh, Julia | Witt, Stephanie, H | Wright, Adam | Zandi, Peter, P | Mitchell, Philip, B | Bauer, Michael | Alda, Martin | Rietschel, Marcella | Mcmahon, Francis, J | Schulze, Thomas, G | Clark, Scott, R | Baune, Bernhard, T
Edité par
CCSD ; Nature Publishing Group -
International audience.
Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental health disorder that affects about 1% of the population worldwide. Nevertheless, lithium is not consistently effective, with only 30% of patients showing a favorable response to treatment. To provide personalized treatment options for bipolar patients, it is essential to identify prediction biomarkers such as polygenic scores. In this study, we developed a polygenic score for lithium treatment response (Li + PGS) in patients with BD. To gain further insights into lithium's possible molecular mechanism of action, we performed a genome-wide gene-based analysis. Using polygenic score modeling, via methods incorporating Bayesian regression and continuous shrinkage priors, Li + PGS was developed in the International Consortium of Lithium Genetics cohort (ConLi + Gen: N = 2367) and replicated in the combined PsyCourse (N = 89) and BipoLife (N = 102) studies. The associations of Li + PGS and lithium treatment responsedefined in a continuous ALDA scale and a categorical outcome (good response vs. poor response) were tested using regression models, each adjusted for the covariates: age, sex, and the first four genetic principal components. Statistical significance was determined at P < 0.05. Li + PGS was positively associated with lithium treatment response in the ConLi + Gen cohort, in both the categorical (P = 9.8 × 10 −12 , R 2 = 1.9%) and continuous (P = 6.4 × 10 −9 , R 2 = 2.6%) outcomes. Compared to bipolar patients in the 1 st decile of the risk distribution, individuals in the 10 th decile had 3.47-fold (95%CI: 2.22-5.47) higher odds of responding favorably to lithium. The results were replicated in the independent cohorts for the categorical treatment outcome (P = 3.9 × 10 −4 , R 2 = 0.9%), but not for the continuous outcome (P = 0.13). Gene-based analyses revealed 36 candidate genes that are enriched in biological pathways controlled by glutamate and acetylcholine. Li + PGS may be useful in the development of pharmacogenomic testing strategies by enabling a classification of bipolar patients according to their response to treatment.
